Delivery Order SPE2DB22D1202-SPE2DB24FVKA0

Award Date 8/6/24
Potential Completion Date 8/7/24
Potential Value $9.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,809.06 firm-fixed-price delivery order is for the supply of 380 mg VIVITROL vials and diluents. The award has a completion date of May 14, 2025 and is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of VIVITROL 380 MG VIAL-DILUENTS. The contract has a ceiling value of $14,698.46 and runs through November 7, 2024. It is a Firm Fixed Price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, involves the delivery of VIVITROL 380 MG VIAL-DILUENTS to support the U.S. government's medical and healthcare needs. The $12,599.09 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of September 30, 2024. The contract does not utilize any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of VIVITROL 380 MG VIAL-DILUENTS. The firm-fixed-price delivery order, valued at $3,003.51, has a completion date of February 11, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award is a Delivery Order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the supply of VIVITROL 380 MG VIAL-DILUENTS, a medication, with a Firm Fixed Price ceiling value of $1,545.19 and a performance period ending on June 30, 2025. The contract is not set aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,001.17 firm fixed-price delivery order is for VIVITROL 380 MG VIAL-DILUENTS and has a completion date of January 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies in...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of VIVITROL 380 MG VIAL-DILUENTS. The contract has a firm fixed price of $3,816.98 and a period of performance through November 21, 2024. The award is a delivery order placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award, valued at $3,783.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of VIVITROL 380 MG VIAL-DILUENTS. The contract is a Firm Fixed Price Delivery Order with a completion date of November 25, 2024. Amerisourcebergen, a major pharmaceutical distributor and healthcare solutions provider, has been awarded this contract as part of its broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, covers the delivery of VIVITROL 380 MG VIAL-DILUENTS to the Defense Logistics Agency (DLA). The contract, valued at $7,635.39, is a firm fixed-price delivery order with a period of performance through November 2023. The contract was awarded on November 22, 2023, and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $17,153.87, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of VIVITROL 380 MG VIAL-DILUENTS, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type. The contract has a period of performance through September 24, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FVKA0
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VIVITROL 380 MG VIAL-DILUENTS. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $9,638.42 and a completion date of August 7, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999, for the delivery of a wide range of pharmaceutical and medical supplies to support military treatment programs and other government healthcare needs. This particular award does not have a set-aside designation.

Generated 11/5/24, 9:03 AM